Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,385 total articles

Barrick Declares Q2 Dividend

Barrick Declares Q2 Dividend

Barrick Mining Corporation announced a quarterly dividend of $0.175 per share for Q2 2026, maintaining its dividend policy targeting a 50% payout of free cash flow annually. The dividend will be paid on September 15, 2026 to shareholders of record on August 31, 2026. The company reiterates its focus on responsible mining and long-term value creatio…

Red Cat Announces Multiyear Partnership with Washington Commanders to Support America's Military Community

Red Cat Announces Multiyear Partnership with Washington Commanders to Support America's Military Community

Red Cat Holdings, Inc., a U.S. provider of advanced drone and robotic solutions for defense, announced a multiyear partnership with the NFL's Washington Commanders. This collaboration focuses on military appreciation initiatives including community events and in-stadium branding throughout the upcoming season, reflecting Red Cat's commitment to sup…

EH216-S Completes Central Asia’s First Pilotless Human-Carrying eVTOL Flight in the Heart of Kazakhstan’s Capital

EH216-S Completes Central Asia’s First Pilotless Human-Carrying eVTOL Flight in the Heart of Kazakhstan’s Capital

EHang Holdings Limited announced that its flagship electric vertical takeoff and landing (eVTOL) aircraft, the EH216-S, successfully completed Central Asia’s first pilotless human-carrying flight in Astana, Kazakhstan. The flight demonstrated EHang’s capabilities under Kazakhstan's newly established regulatory framework, highlighting partnerships f…

Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company

Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company

Oculis Holding AG has signed an asset purchase agreement with Accure Therapeutics to acquire worldwide rights to the neuroprotective drug candidate Privosegtor and an early-stage preclinical drug ACT-02. This acquisition will terminate the existing license agreement with Accure, eliminating milestone payments and royalties, and allow Oculis to full…

RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges

RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges

RadNet, Inc. announced strong financial results for Q2 2026 with record total revenue of $622.7 million, a 25% increase year-over-year, and adjusted EBITDA of $99.7 million, up 22.7%. Significant growth in the Digital Health segment, with revenue up 56.5%, and expansion in advanced imaging procedures contributed to the positive results. The company…

Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Braveheart Bio, a clinical-stage biopharmaceutical company developing treatments for hypertrophic cardiomyopathy and other cardiovascular diseases, announced the closing of its upsized initial public offering (IPO) of approximately 24.4 million shares at $18.00 each, including full exercise of underwriters' option. The IPO raised $439.9 million gro…

Hawkins, Inc. to Participate in Seaport Research Partners’ 15th Annual Summer Investor Conference

Hawkins, Inc. to Participate in Seaport Research Partners’ 15th Annual Summer Investor Conference

Hawkins, Inc., a leading water treatment and specialty ingredients company, announced that its CEO and CFO will participate in Seaport Research Partners’ virtual 15th Annual Summer Investor Conference in August 2026. The event draws over 500 institutional investors and features interactive meetings. Hawkins aims to engage with investors and provide…

Amwell makes grant to new employees under inducement plan

Amwell makes grant to new employees under inducement plan

Amwell granted restricted stock units (RSUs) totaling 6,679 shares to two new non-executive employees as inducement for joining the company. The RSUs vest over four years, with an initial 25% vesting at one year and the remainder quarterly thereafter. This move follows the company's 2024 Inducement Plan and complies with NYSE rules. Amwell is a lea…

Globus Maritime Limited Reports Financial Results for the Second Quarter and Six-Month Period Ended June 30, 2026

Globus Maritime Limited Reports Financial Results for the Second Quarter and Six-Month Period Ended June 30, 2026

Globus Maritime Limited announced solid financial results for Q2 and the first half of 2026, with significant revenue and adjusted EBITDA growth driven by improved market conditions in the dry bulk shipping sector. The company continues operating a fleet of nine dry bulk carriers, primarily on spot and short-term charters, and is nearing completion…

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans

NRx Pharmaceuticals announced a conference call on August 10 to discuss the FDA's first-cycle review completion of its Abbreviated New Drug Application (ANDA) for preservative-free ketamine (NRX-100). The company will cover regulatory progress and commercial plans for this clinical-stage biopharmaceutical product targeting central nervous system di…